[1] Wann L S, Curtis A B, January C T, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Update on Dabigatran)[J]. J Am Coll Cardiol, 2011, 57(11): 1330 [2] Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mechanisms of atrial fibrillation: A translational appraisal[J]. Physiol Rev, 2011, 91(1): 265 [3] Everett T H 4th, Olgin J E. Atrial fibrosis and the mechanisms of atrial fibrillation[J]. Heart Rhythm, 2007, 4(3 Suppl): 24 [4] Nishida K, Michael G, Dobrev D, et al. Animal models for atrial fibrillation: clinical insights and scientific opportunities[J]. Europace, 2010, 12(2): 160 [5] Riley G, Syeda F, Kirchhof P, et al. An introduction to murine models of atrial fibrillation[J]. Front Physiol, 2012, 8(3): 296 [6] Ramos P, Rubies C, Torres M, et al. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells[J]. Respir Res, 2014, 15(1): 54 [7] Qu Y C, Du Y M, Wu S L, et al. Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation [J]. Scand Cardiovasc J, 2009, 43(5): 292 [8] Katoh Y, Nakazato Y J. Can we predict electroanatomical remodeling of left atrium in patients with non-valvular atrial fibrillation by transforming growth factor-β and tissue inhibitor of metalloproteinase-1[J]. Circ J, 2011, 75(3): 536 [9] Diao S L, Xu H P, Zhang B, et al. Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation[J]. Med Sci Monit, 2016, 22: 1497 [10] Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends in cardiovascular medicine[J]. Trends Cardiovasc Med, 2015, 25(6): 475 [11] Wang J, Wang Y, Han J, et al. Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal[J]. Heart Rhythm, 2015, 12(5): 1018 [12] Santulli G, Iaccarino G, De Luca N, et al. Atrial fibrillation and microRNAs[J]. Front Physiol, 2014, 5: 15 [13] Barana A, Matamoros M, Dolz-Gaiton P, et al. Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current[J]. Circ Arrhythm Electrophysiol, 2014, 7(5): 861 [14]Satoh A, Niwano S, Niwano H, et al. Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation[J]. Heart Vessels, 2017, 32(1): 90 [15]Fu H, Liu C, Li J, et al. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits[J]. Cardiol J, 2013, 20(1): 59
作者简介 张凯(1991-),男,硕士在读,研究方向:心律失常;通信作者:李广平,E-mail:tjcardiol@126.com。